| Citation: |
YAO Binbin, SHEN Yan, YANG Hongli, FENG Sujuan, HUANG Huaxing, ZHU Xueling, SHEN Lianglan. Impact of serum cystatin C and hypersensitivity C-reactive protein on the 3-year survival of patients undergoing maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 68-75, 80. DOI: 10.7619/jcmp.20240283
|
To investigate the influence of serum cystatin C (Cys-C) and hypersensitivity C-reactive protein (hs-CRP) levels on the 3-year survival of patients undergoing maintenance hemodialysis (MHD).
A total of 358 patients with chronic renal failure who underwent MHD at the Second Affiliated Hospital of Nantong University from April 2011 to October 2020 were selected as study subjects. General clinical data, pre-dialysis laboratory test indicators, and echocardiographic indicators 3 months after dialysis were recorded. The survival status of patients after 3 years of dialysis was followed up, and the general clinical data, pre-dialysis laboratory test indicators, and echocardiographic indicators 3 months after dialysis were compared between surviving and deceased patients. Univariate and multivariate Cox regression analyses were performed to screen influencing factors of 3-year survival in MHD patients.
At the 3-year follow-up, of the 302 MHD patients' 203 survived, and 99 died. Statistically significant differences were observed in age, primary disease, diabetes status, congestive heart failure, statin use, antiplatelet drug use, diuretic use, dialysis mode, estimated glomerular filtration rate (eGFR) and gamma-glutamyl transferase (GGT), alkaline phosphatase (AKP), total bilirubin (TBIL), β2-microglobulin (β2-MG), creatinine (Cr), low-density lipoprotein cholesterol (LDL-C), hypersensitive C-reactive protein (hs-CRP), and serum phosphorus (P) levels between surviving patients and deaths(P < 0.05 or P < 0.01). Univariate Cox regression results showed that age of MHD patients, primary disease (diabetic nephropathy, hypertensive nephropathy, polycystic kidney disease, others), comorbidities(diabetes, congestive heart failure, other cardiovascular diseases), drug use (statins, antiplatelet drugs), dialysis method (hemodialysis, hemodialysis + perfusion), laboratory test indicators [GGT, AKP, TBIL, total bile acid (TBA), albumin (ALB), Cr, Cys-C, eGFR, apolipoprotein A (APO-A), hs-CRP]were all influential factors of 3-year survival rate of MHD patients. Multivariate Cox regression analysis revealed that age, primary disease, other cardiovascular diseases, dialysis mode, AKP, ALB, TBIL, Cys-C, and hs-CRP were significant influencing factors for the survival of patients with chronic renal failure (P < 0.05).
Serum Cys-C and hs-CRP levels before MHD in patients with chronic renal failure may be associated with their 3-year survival after dialysis treatment. High serum Cys-C may reduce the risk of poor clinical prognosis, while high serum hs-CRP may increase the risk of poor clinical prognosis.
| [1] |
CHEN X J, MAO Y, HU J B, et al. Perirenal fat thickness is significantly associated with the risk for development of chronic kidney disease in patients with diabetes[J]. Diabetes, 2021, 70(10): 2322-2332. doi: 10.2337/db20-1031
|
| [2] |
MORIMATSU M, ONO K, HARADA A. Severe asterixis due to hypermagnesemia in chronic renal failure: a case report[J]. Neurol Sci, 2021, 42(6): 2539-2542. doi: 10.1007/s10072-020-04945-x
|
| [3] |
吕晴, 陈卫东, 刘磊. 维持性血液透析患者肾性贫血的多因素分析及相关性研究[J]. 中华全科医学, 2021, 19(5): 871-874.
|
| [4] |
LUO L M, XIAO C L, XIANG Q, et al. Significant increase of sexual dysfunction in patients with renal failure receiving renal replacement therapy: a systematic review and meta-analysis[J]. J Sex Med, 2020, 17(12): 2382-2393. doi: 10.1016/j.jsxm.2020.08.019
|
| [5] |
GUO M, PIERRE E S, CLEMENCE J Jr, et al. Impact of chronic renal failure on surgical outcomes in patients with infective endocarditis[J]. Ann Thorac Surg, 2021, 111(3): 828-835. doi: 10.1016/j.athoracsur.2020.06.023
|
| [6] |
SHOSHTARI F S, BIRANVAND S, REZAEI L, et al. The impact of hemodialysis on retinal and choroidal thickness in patients with chronic renal failure[J]. Int Ophthalmol, 2021, 41(5): 1763-1771. doi: 10.1007/s10792-021-01735-y
|
| [7] |
HE L, LI J, ZHAN J, et al. The value of serum cystatin C in early evaluation of renal insufficiency inpatients undergoing chemotherapy: a systematic review and Meta-analysis[J]. Cancer Chemother Pharmacol, 2019, 83(3): 561-571.
|
| [8] |
易丽萍, 张悦凤, 李玉明, 等. 血清HbA1c、IL-6、CysC与老年糖尿病肾病患者病变严重程度的相关性[J]. 中国老年学杂志, 2020, 40(18): 3843-3845.
|
| [9] |
COHAN C M, BEATTIE G, TANG A N, et al. Early monocyte chemoattractant protein-1 elevation predicts surgical site infections after blunt trauma[J]. Surg Infect, 2021, 22(7): 690-696. doi: 10.1089/sur.2020.141
|
| [10] |
NEVEN E, CORREMANS R, VERVAET B A, et al. Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure[J]. Nephrol Dial Transplant, 2020, 35(10): 1689-1699. doi: 10.1093/ndt/gfaa080
|
| [11] |
ZHANG L X, ZHAO M H, ZUO L, et al. China kidney disease network (CK-NET) 2016 annual data report[J]. Kidney Int Suppl, 2020, 10(2): e97-e185. doi: 10.1016/j.kisu.2020.09.001
|
| [12] |
胡旦翔, 黄佩佩, 张静, 等. 中青年慢性肾衰竭血液透析患者的正性心理和社会支持对生活质量影响的分析[J]. 中国中西医结合肾病杂志, 2021, 22(11): 1016-1018.
|
| [13] |
KITAMURA M, YAMAGUCHI K, OTA Y, et al. Prognostic impact of polypharmacy by drug essentiality in patients onhemodialysis[J]. Sci Rep, 2021, 11(1): 24238. doi: 10.1038/s41598-021-03772-0
|
| [14] |
WALLACE Z S, WALLWORK R, ZHANG Y Q, et al. Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System[J]. Ann Rheum Dis, 2018, 77(9): 1333-1338. doi: 10.1136/annrheumdis-2018-213452
|
| [15] |
WANG F, YANG C, LONG J, et al. Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET) [J]. Kidney Int, 2019, 96(2): 525. doi: 10.1016/j.kint.2019.05.004
|
| [16] |
马琴琴, 周莹, 张艳楠, 等. 连续肾替代治疗慢性肾衰竭重症患者的疗效及其预后的影响因素分析[J]. 临床肾脏病杂志, 2022, 22(9): 712-718.
|
| [17] |
张妍, 荣阳, 张芳. CRRT治疗肾衰竭合并顽固性心力衰竭的临床效果[J]. 中西医结合心脑血管病杂志, 2022, 20(2): 285-288.
|
| [18] |
孙园园. 血液透析滤过联合血液透析治疗慢性肾衰竭的临床疗效及对肾功能的影响[J]. 临床研究, 2024, 32(8): 82-85.
|
| [19] |
刘红, 回雪玲, 刘书馨. 不同通量透析对尿毒症患者5年远期预后的影响[J]. 中国慢性病预防与控制, 2022, 30(4): 286-289.
|
| [20] |
ISHIWATARI A, YAMAMOTO S, FUKUMA S, et al. Changes in quality of life in older hemodialysis patients: a cohort study on dialysis outcomes and practice patterns[J]. Am J Nephrol, 2020, 51(8): 650-658. doi: 10.1159/000509309
|
| [21] |
CHEN C, ZHANG J, ZHOU Z M, et al. Impact of serum albumin level and variability on short-term cardiovascular-related and all-cause mortality in patients on maintenance hemodialysis[J]. Medicine, 2021, 100(43): e27666. doi: 10.1097/MD.0000000000027666
|
| [22] |
李晓玲, 周文杰, 邓伟, 等. 凝血指标联合血清胱抑素C对脓毒症急性肾损伤患者预后的预测价值[J]. 实用医学杂志, 2023, 39(1): 81-85.
|
| [23] |
SALGADO J V, SOUZA F L, SALGADO B J. How to understand the association between cystatin C levels and cardiovascular disease: imbalance, counterbalance, or consequence[J]. J Cardiol, 2013, 62(6): 331-335. doi: 10.1016/j.jjcc.2013.05.015
|
| [24] |
ITO S, MANABE E, DAI Y, et al. Juzentaihoto improves adenine-induced chronic renal failure in BALB/c mice via suppression of renal fibrosis and inflammation[J]. J Pharmacol Sci, 2022, 148(1): 172-178.
|
| [25] |
祝存奎, 朱芳一, 戴婧, 等. 青海高原地区不同海拔世居藏族和汉族慢性心力衰竭患者血清N末端脑钠肽前体、超敏C反应蛋白及炎性因子水平变化及其与预后的关系研究[J]. 实用心脑肺血管病杂志, 2020, 28(4): 28-33.
|
| [26] |
WOZNY Ł, ZYWIEC J, GOSEK K, et al. Association of CX3CR1 gene polymorphisms with fractalkine, fractalkine receptor, and C-reactive protein levels in patients with kidney failure[J]. Int J Environ Res Public Health, 2021, 18(4): 2202.
|
| [27] |
FAN Y, JIN X, JIANG M L, et al. Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: a meta-analysis[J]. Sci Rep, 2017, 7(1): 13224.
|
| [28] |
SU H H, KAO C M, LIN Y C, et al. Relationship between serum total bilirubin levels and mortality in uremia patients undergoing long-term hemodialysis: a nationwide cohort study[J]. Atherosclerosis, 2017, 265: 155-161.
|
| [29] |
LI J, LIU D W, LIU Z S. Serum total bilirubin and progression of chronic kidney disease and mortality: a systematic review and meta-analysis[J]. Front Med, 2020, 7: 549.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: